News Conference News EuroPCR 2023 ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure Todd Neale May 18, 2023
News Conference News EuroPCR 2022 Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO Yael L. Maxwell May 23, 2022
News Conference News EuroPCR 2020 ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead Yael L. Maxwell July 03, 2020
News Conference News EuroPCR 2019 New Clarity on Patients at High Risk for Bleeding After PCI Michael O'Riordan May 28, 2019
News Conference News EuroPCR 2019 Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years Michael O'Riordan May 27, 2019
News Conference News EuroPCR 2019 BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels L.A. McKeown May 22, 2019
News Conference News EuroPCR 2018 STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP? Caitlin E. Cox May 31, 2018
News Conference News EuroPCR 2018 New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes Michael O'Riordan May 25, 2018
News Conference News EuroPCR 2017 FFR-SEARCH Explores Potential of Physiologic Assessment After PCI Caitlin E. Cox May 18, 2017
News Conference News EuroPCR 2017 TOPIC: Replacing P2Y12 Inhibitors With Clopidogrel 1 Month After PCI Saves Money, Prevents Bleeding in ACS Yael L. Maxwell May 16, 2017
News Conference News EuroPCR 2014 PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities Yael L. Maxwell May 21, 2014
News Conference News EuroPCR 2012 Strong Showing for Bioabsorbable-Scaffold DES Caitlin E. Cox May 16, 2012
News Conference News EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out May 23, 2011
News Conference News RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose Caitlin E. Cox May 18, 2011